aluates Reports

$ 0.0

Automative

Global Gene Therapy in Cardiovascular Disorder Market Research Report 2025

Published Date: April 2025

Report Code: QYRE-Auto-14W13809

Global Gene Therapy in Cardiovascular Disorder Market Research Report 2023

BUY CHAPTERS

Global Gene Therapy in Cardiovascular Disorder Market Research Report 2025

Code: QYRE-Auto-14W13809

Report

April 2025

Pages:64

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Gene Biotherapeutics

Askbio

Human Stem Cells Institute

Novartis

Renovacor

Gene Therapy in Cardiovascular Disorder Market Size

The global market for Gene Therapy in Cardiovascular Disorder was valued at US$ 509 million in the year 2024 and is projected to reach a revised size of US$ 1914 million by 2031, growing at a CAGR of 21.1% during the forecast period.

Gene Therapy in Cardiovascular Disorder Market

Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient"s cells instead of using drugs or surgery.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Gene Therapy in Cardiovascular Disorder, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapy in Cardiovascular Disorder.

The Gene Therapy in Cardiovascular Disorder market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gene Therapy in Cardiovascular Disorder market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Gene Therapy in Cardiovascular Disorder companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Gene Therapy in Cardiovascular Disorder Market Report

Report Metric	Details
Report Name	Gene Therapy in Cardiovascular Disorder Market
Accounted market size in year	US$ 509 million
Forecasted market size in 2031	US$ 1914 million
CAGR	21.1%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Viral Gene Therapy Non-viral Gene Therapy
Segment by Application	Heart Disease Vascular Disease
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Renovacor, Gene Biotherapeutics, AskBio, Human Stem Cells Institute, Novartis
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Therapy in Cardiovascular Disorder company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Gene Therapy in Cardiovascular Disorder Market growing?

Ans: The Gene Therapy in Cardiovascular Disorder Market witnessing a CAGR of 21.1% during the forecast period 2025-2031.

What is the Gene Therapy in Cardiovascular Disorder Market size in 2031?

Ans: The Gene Therapy in Cardiovascular Disorder Market size in 2031 will be US$ 1914 million.

Who are the main players in the Gene Therapy in Cardiovascular Disorder Market report?

Ans: The main players in the Gene Therapy in Cardiovascular Disorder Market are Renovacor, Gene Biotherapeutics, AskBio, Human Stem Cells Institute, Novartis

What are the Application segmentation covered in the Gene Therapy in Cardiovascular Disorder Market report?

Ans: The Applications covered in the Gene Therapy in Cardiovascular Disorder Market report are Heart Disease, Vascular Disease

What are the Type segmentation covered in the Gene Therapy in Cardiovascular Disorder Market report?

Ans: The Types covered in the Gene Therapy in Cardiovascular Disorder Market report are Viral Gene Therapy, Non-viral Gene Therapy

Recommended Reports

Gene Therapy Markets

Cardiovascular Disease Care

Gene Therapy Tools

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Gene Therapy in Cardiovascular Disorder Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Viral Gene Therapy

1.2.3 Non-viral Gene Therapy

1.3 Market by Application

1.3.1 Global Gene Therapy in Cardiovascular Disorder Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Heart Disease

1.3.3 Vascular Disease

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Gene Therapy in Cardiovascular Disorder Market Perspective (2020-2031)

2.2 Global Gene Therapy in Cardiovascular Disorder Growth Trends by Region

2.2.1 Global Gene Therapy in Cardiovascular Disorder Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Gene Therapy in Cardiovascular Disorder Historic Market Size by Region (2020-2025)

2.2.3 Gene Therapy in Cardiovascular Disorder Forecasted Market Size by Region (2026-2031)

2.3 Gene Therapy in Cardiovascular Disorder Market Dynamics

2.3.1 Gene Therapy in Cardiovascular Disorder Industry Trends

2.3.2 Gene Therapy in Cardiovascular Disorder Market Drivers

2.3.3 Gene Therapy in Cardiovascular Disorder Market Challenges

2.3.4 Gene Therapy in Cardiovascular Disorder Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Gene Therapy in Cardiovascular Disorder Players by Revenue

3.1.1 Global Top Gene Therapy in Cardiovascular Disorder Players by Revenue (2020-2025)

3.1.2 Global Gene Therapy in Cardiovascular Disorder Revenue Market Share by Players (2020-2025)

3.2 Global Gene Therapy in Cardiovascular Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Gene Therapy in Cardiovascular Disorder Revenue

3.4 Global Gene Therapy in Cardiovascular Disorder Market Concentration Ratio

3.4.1 Global Gene Therapy in Cardiovascular Disorder Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy in Cardiovascular Disorder Revenue in 2024

3.5 Global Key Players of Gene Therapy in Cardiovascular Disorder Head office and Area Served

3.6 Global Key Players of Gene Therapy in Cardiovascular Disorder, Product and Application

3.7 Global Key Players of Gene Therapy in Cardiovascular Disorder, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Gene Therapy in Cardiovascular Disorder Breakdown Data by Type

4.1 Global Gene Therapy in Cardiovascular Disorder Historic Market Size by Type (2020-2025)

4.2 Global Gene Therapy in Cardiovascular Disorder Forecasted Market Size by Type (2026-2031)

5 Gene Therapy in Cardiovascular Disorder Breakdown Data by Application

5.1 Global Gene Therapy in Cardiovascular Disorder Historic Market Size by Application (2020-2025)

5.2 Global Gene Therapy in Cardiovascular Disorder Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Gene Therapy in Cardiovascular Disorder Market Size (2020-2031)

6.2 North America Gene Therapy in Cardiovascular Disorder Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Gene Therapy in Cardiovascular Disorder Market Size by Country (2020-2025)

6.4 North America Gene Therapy in Cardiovascular Disorder Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Gene Therapy in Cardiovascular Disorder Market Size (2020-2031)

7.2 Europe Gene Therapy in Cardiovascular Disorder Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Gene Therapy in Cardiovascular Disorder Market Size by Country (2020-2025)

7.4 Europe Gene Therapy in Cardiovascular Disorder Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Gene Therapy in Cardiovascular Disorder Market Size (2020-2031)

8.2 Asia-Pacific Gene Therapy in Cardiovascular Disorder Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Gene Therapy in Cardiovascular Disorder Market Size by Region (2020-2025)

8.4 Asia-Pacific Gene Therapy in Cardiovascular Disorder Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Gene Therapy in Cardiovascular Disorder Market Size (2020-2031)

9.2 Latin America Gene Therapy in Cardiovascular Disorder Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Gene Therapy in Cardiovascular Disorder Market Size by Country (2020-2025)

9.4 Latin America Gene Therapy in Cardiovascular Disorder Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Gene Therapy in Cardiovascular Disorder Market Size (2020-2031)

10.2 Middle East & Africa Gene Therapy in Cardiovascular Disorder Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Gene Therapy in Cardiovascular Disorder Market Size by Country (2020-2025)

10.4 Middle East & Africa Gene Therapy in Cardiovascular Disorder Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Renovacor

11.1.1 Renovacor Company Details

11.1.2 Renovacor Business Overview

11.1.3 Renovacor Gene Therapy in Cardiovascular Disorder Introduction

11.1.4 Renovacor Revenue in Gene Therapy in Cardiovascular Disorder Business (2020-2025)

11.1.5 Renovacor Recent Development

11.2 Gene Biotherapeutics

11.2.1 Gene Biotherapeutics Company Details

11.2.2 Gene Biotherapeutics Business Overview

11.2.3 Gene Biotherapeutics Gene Therapy in Cardiovascular Disorder Introduction

11.2.4 Gene Biotherapeutics Revenue in Gene Therapy in Cardiovascular Disorder Business (2020-2025)

11.2.5 Gene Biotherapeutics Recent Development

11.3 AskBio

11.3.1 AskBio Company Details

11.3.2 AskBio Business Overview

11.3.3 AskBio Gene Therapy in Cardiovascular Disorder Introduction

11.3.4 AskBio Revenue in Gene Therapy in Cardiovascular Disorder Business (2020-2025)

11.3.5 AskBio Recent Development

11.4 Human Stem Cells Institute

11.4.1 Human Stem Cells Institute Company Details

11.4.2 Human Stem Cells Institute Business Overview

11.4.3 Human Stem Cells Institute Gene Therapy in Cardiovascular Disorder Introduction

11.4.4 Human Stem Cells Institute Revenue in Gene Therapy in Cardiovascular Disorder Business (2020-2025)

11.4.5 Human Stem Cells Institute Recent Development

11.5 Novartis

11.5.1 Novartis Company Details

11.5.2 Novartis Business Overview

11.5.3 Novartis Gene Therapy in Cardiovascular Disorder Introduction

11.5.4 Novartis Revenue in Gene Therapy in Cardiovascular Disorder Business (2020-2025)

11.5.5 Novartis Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Gene Biotherapeutics

Askbio

Human Stem Cells Institute

Novartis

Renovacor

List of Tables

Table 1. Global Gene Therapy in Cardiovascular Disorder Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Viral Gene Therapy

Table 3. Key Players of Non-viral Gene Therapy

Table 4. Global Gene Therapy in Cardiovascular Disorder Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Gene Therapy in Cardiovascular Disorder Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Gene Therapy in Cardiovascular Disorder Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Gene Therapy in Cardiovascular Disorder Market Share by Region (2020-2025)

Table 8. Global Gene Therapy in Cardiovascular Disorder Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Gene Therapy in Cardiovascular Disorder Market Share by Region (2026-2031)

Table 10. Gene Therapy in Cardiovascular Disorder Market Trends

Table 11. Gene Therapy in Cardiovascular Disorder Market Drivers

Table 12. Gene Therapy in Cardiovascular Disorder Market Challenges

Table 13. Gene Therapy in Cardiovascular Disorder Market Restraints

Table 14. Global Gene Therapy in Cardiovascular Disorder Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Gene Therapy in Cardiovascular Disorder Market Share by Players (2020-2025)

Table 16. Global Top Gene Therapy in Cardiovascular Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy in Cardiovascular Disorder as of 2024)

Table 17. Ranking of Global Top Gene Therapy in Cardiovascular Disorder Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Gene Therapy in Cardiovascular Disorder Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Gene Therapy in Cardiovascular Disorder, Headquarters and Area Served

Table 20. Global Key Players of Gene Therapy in Cardiovascular Disorder, Product and Application

Table 21. Global Key Players of Gene Therapy in Cardiovascular Disorder, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Gene Therapy in Cardiovascular Disorder Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Gene Therapy in Cardiovascular Disorder Revenue Market Share by Type (2020-2025)

Table 25. Global Gene Therapy in Cardiovascular Disorder Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Gene Therapy in Cardiovascular Disorder Revenue Market Share by Type (2026-2031)

Table 27. Global Gene Therapy in Cardiovascular Disorder Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Gene Therapy in Cardiovascular Disorder Revenue Market Share by Application (2020-2025)

Table 29. Global Gene Therapy in Cardiovascular Disorder Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Gene Therapy in Cardiovascular Disorder Revenue Market Share by Application (2026-2031)

Table 31. North America Gene Therapy in Cardiovascular Disorder Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Gene Therapy in Cardiovascular Disorder Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Gene Therapy in Cardiovascular Disorder Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Gene Therapy in Cardiovascular Disorder Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Gene Therapy in Cardiovascular Disorder Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Gene Therapy in Cardiovascular Disorder Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Gene Therapy in Cardiovascular Disorder Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Gene Therapy in Cardiovascular Disorder Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Gene Therapy in Cardiovascular Disorder Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Gene Therapy in Cardiovascular Disorder Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Gene Therapy in Cardiovascular Disorder Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Gene Therapy in Cardiovascular Disorder Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Gene Therapy in Cardiovascular Disorder Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Gene Therapy in Cardiovascular Disorder Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Gene Therapy in Cardiovascular Disorder Market Size by Country (2026-2031) & (US$ Million)

Table 46. Renovacor Company Details

Table 47. Renovacor Business Overview

Table 48. Renovacor Gene Therapy in Cardiovascular Disorder Product

Table 49. Renovacor Revenue in Gene Therapy in Cardiovascular Disorder Business (2020-2025) & (US$ Million)

Table 50. Renovacor Recent Development

Table 51. Gene Biotherapeutics Company Details

Table 52. Gene Biotherapeutics Business Overview

Table 53. Gene Biotherapeutics Gene Therapy in Cardiovascular Disorder Product

Table 54. Gene Biotherapeutics Revenue in Gene Therapy in Cardiovascular Disorder Business (2020-2025) & (US$ Million)

Table 55. Gene Biotherapeutics Recent Development

Table 56. AskBio Company Details

Table 57. AskBio Business Overview

Table 58. AskBio Gene Therapy in Cardiovascular Disorder Product

Table 59. AskBio Revenue in Gene Therapy in Cardiovascular Disorder Business (2020-2025) & (US$ Million)

Table 60. AskBio Recent Development

Table 61. Human Stem Cells Institute Company Details

Table 62. Human Stem Cells Institute Business Overview

Table 63. Human Stem Cells Institute Gene Therapy in Cardiovascular Disorder Product

Table 64. Human Stem Cells Institute Revenue in Gene Therapy in Cardiovascular Disorder Business (2020-2025) & (US$ Million)

Table 65. Human Stem Cells Institute Recent Development

Table 66. Novartis Company Details

Table 67. Novartis Business Overview

Table 68. Novartis Gene Therapy in Cardiovascular Disorder Product

Table 69. Novartis Revenue in Gene Therapy in Cardiovascular Disorder Business (2020-2025) & (US$ Million)

Table 70. Novartis Recent Development

Table 71. Research Programs/Design for This Report

Table 72. Key Data Information from Secondary Sources

Table 73. Key Data Information from Primary Sources

Table 74. Authors List of This Report

List of Figures

Figure 1. Gene Therapy in Cardiovascular Disorder Picture

Figure 2. Global Gene Therapy in Cardiovascular Disorder Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Gene Therapy in Cardiovascular Disorder Market Share by Type: 2024 VS 2031

Figure 4. Viral Gene Therapy Features

Figure 5. Non-viral Gene Therapy Features

Figure 6. Global Gene Therapy in Cardiovascular Disorder Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Gene Therapy in Cardiovascular Disorder Market Share by Application: 2024 VS 2031

Figure 8. Heart Disease Case Studies

Figure 9. Vascular Disease Case Studies

Figure 10. Gene Therapy in Cardiovascular Disorder Report Years Considered

Figure 11. Global Gene Therapy in Cardiovascular Disorder Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 12. Global Gene Therapy in Cardiovascular Disorder Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Gene Therapy in Cardiovascular Disorder Market Share by Region: 2024 VS 2031

Figure 14. Global Gene Therapy in Cardiovascular Disorder Market Share by Players in 2024

Figure 15. Global Top Gene Therapy in Cardiovascular Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy in Cardiovascular Disorder as of 2024)

Figure 16. The Top 10 and 5 Players Market Share by Gene Therapy in Cardiovascular Disorder Revenue in 2024

Figure 17. North America Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 18. North America Gene Therapy in Cardiovascular Disorder Market Share by Country (2020-2031)

Figure 19. United States Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. Canada Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Europe Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Gene Therapy in Cardiovascular Disorder Market Share by Country (2020-2031)

Figure 23. Germany Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. France Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. U.K. Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Italy Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Russia Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Nordic Countries Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Asia-Pacific Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Gene Therapy in Cardiovascular Disorder Market Share by Region (2020-2031)

Figure 31. China Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Japan Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. South Korea Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Southeast Asia Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. India Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Australia Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Latin America Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Gene Therapy in Cardiovascular Disorder Market Share by Country (2020-2031)

Figure 39. Mexico Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Brazil Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Middle East & Africa Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Gene Therapy in Cardiovascular Disorder Market Share by Country (2020-2031)

Figure 43. Turkey Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Saudi Arabia Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. UAE Gene Therapy in Cardiovascular Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Renovacor Revenue Growth Rate in Gene Therapy in Cardiovascular Disorder Business (2020-2025)

Figure 47. Gene Biotherapeutics Revenue Growth Rate in Gene Therapy in Cardiovascular Disorder Business (2020-2025)

Figure 48. AskBio Revenue Growth Rate in Gene Therapy in Cardiovascular Disorder Business (2020-2025)

Figure 49. Human Stem Cells Institute Revenue Growth Rate in Gene Therapy in Cardiovascular Disorder Business (2020-2025)

Figure 50. Novartis Revenue Growth Rate in Gene Therapy in Cardiovascular Disorder Business (2020-2025)

Figure 51. Bottom-up and Top-down Approaches for This Report

Figure 52. Data Triangulation

Figure 53. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Gene Therapy based Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Gene Therapy on Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drug Based on Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Gene Delivery System Technology Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Gene based Advanced Therapy Medical Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Gene Therapy on Neurological Diseases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gene based Therapy Medicinal Market Research Report 2024

Global Gene Therapy Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Global Gene based Advanced Therapy Medicinal Market Research Report 2025

Global Gene Delivery or Gene Therapy Drug Market Research Report 2025

Drugs Based on Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Human Gene Therapy Market Research Report 2025

Global Gene Delivery System Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030

Viral Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Gene Therapy in CNS Disorder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gene Therapy For Cancer Market Research Report 2024

Global Gene Therapy for CNS Disorders Market Research Report 2024

Global Advanced Therapy Based on Gene Market Research Report 2025

Global Gene Therapies for Cancer Treatment Market Research Report 2024

RELATED REPORTS

Global Insulin Coolers Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19Z7671

Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Ossicular Prostheses Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10V14317

Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Defibrillator Accessories Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10O5919

Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Septicemia Diagnostic Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-4I19963

Thu Sep 18 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions